Preview

South Russian Journal of Cancer

Advanced search

Area of combined surgical interventions, including those with an angiosurgical component, in terms of malignant non-organ retroperitoneal tumors’ treatment

https://doi.org/10.37748/2686-9039-2023-4-4-1

EDN: APGIHL

Abstract

Purpose of the study. To analyze the immediate outcomes following surgical treatment of locally advanced malignant non-organ retroperitoneal tumors (NRT).

Materials and methods. Surgical interventions for malignant NRTs were performed in 114 patients at Abdominal Oncology Department № 1, National Medical Research Centre for Oncology.There were 48 males and 66 females among them. According to the histological structure, liposarcoma was commonly detected in 64 (56.1 %) cases.

Results. Intraoperative revision revealed the spread of the tumor to adjacent anatomical structures in 67 (58.8 %) cases. Resection surgical interventions were performed in 109 patients, of which 106 (97.2 %) patients had operations performed in an amount of R0. Combined surgical interventions for NRTs were performed in 62 (54.4 %) patients, and multiorgan happened to be in 45 (72.6 %) patients out of those. Resection of the inferior vena cava was performed in 12 patients. Resection of the superior mesenteric vein was performed in 2 patients and the iliac-colonic vein in 2 patients. In 1 observation the left renal vein was resected with suturing of the lateral defect of the vessel wall. Complications during surgery and in the early postoperative period were noted in 14 (12.3 %) patients. In total, 2 patients died after operations, the mortality rate was 1.8 %.

Conclusions. Tumor invasion of big main blood vessels is not a contraindication for surgical treatment of locally spread malignant non-organ retroperitoneal tumors.

About the Authors

O. I. Kit
National Medical Research Centre for Oncology
Russian Federation

 

Oleg I. Kit – Academician at the Russian Academy of Sciences, Dr. Sci. (Med.), professor, general director, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.

ORCID: https://orcid.org/0000-0003-3061-6108, SPIN: 1728-0329, AuthorID: 343182, ResearcherID: U-2241-2017, Scopus Author ID: 55994103100


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



A. A. Maslov
National Medical Research Centre for Oncology
Russian Federation

 

Andrey A. Maslov – Dr. Sci. (Med.), professor, chief doctor, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.

ORCID: https://orcid.org/0000-0001-7328-8074, SPIN: 5963-5915, AuthorID: 817983


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



E. N. Kolesnikov
National Medical Research Centre for Oncology
Russian Federation

 

Evgenii N. Kolesnikov – Dr. Sci. (Med.), senior researcher, head of the department of abdominal oncology No. 1, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.

ORCID: https://orcid.org/0000-0002-8436-7250, SPIN: 8434-6494, AuthorID: 347457


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



O. V. Katelnitskaya
National Medical Research Centre for Oncology
Russian Federation

 

Oksana V. Katelnitskaya – Cand. Sci. (Med.), MD, cardiovascular surgeon, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation. 

ORCID: https://orcid.org/0000-0002-7777-9943, SPIN: 6459-0334, AuthorID: 834607


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



M. A. Kozhushko
National Medical Research Centre for Oncology
Russian Federation

 

Mikhail A. Kozhushko – Cand. Sci. (Med.), MD, abdominal surgeon, researcher, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation. 

SPIN: 9067-6410, AuthorID: 346250


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



A. V. Snezhko
National Medical Research Centre for Oncology; Rostov State Medical University
Russian Federation

 

leksandr V. Snezhko – Dr. Sci. (Med.), MD, surgeon at the abdominal oncology department No. 1, National Medical Research Center for Oncology, Rostov-on-Don, Russian Federation; assistant of the department for oncology, Rostov State Medical University, Rostov-on-Don, Russian Federation.

ORCID: https://orcid.org/0000-0003-3998-8004, SPIN: 2913-3744, AuthorID: 439135, Scopus Author ID: 6701854863


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



T. B. Katsieva
National Medical Research Centre for Oncology
Russian Federation

 

Tanzila B. Katsieva – Cand. Sci. (Med.), MD, surgeon, senior research fellow, National Medical Research Center for Oncology, Rostov-on-Don, Russian Federation.

SPIN: 2069-9778, AuthorID: 735754


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



R. E. Myagkov
National Medical Research Centre for Oncology
Russian Federation

 

Roman E. Myagkov – Cand. Sci. (Med.), MD, surgeon, National Medical Research Center for Oncology, Rostov-on-Don, Russian Federation.

SPIN: 6109-7094, AuthorID: 737500


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



S. V. Sanamyants
National Medical Research Centre for Oncology
Russian Federation

 

Sergei V. Sanamyants – Cand. Sci. (Med.), oncologist, National Medical Research Center for Oncology, Rostov-on-Don, Russian Federation.

ORCID: https://orcid.org/0000-0001-5687-6229

 


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



A. E. Anisimov
National Medical Research Centre for Oncology
Russian Federation

 

Aleksandr E. Anisimov – oncologist, National Medical Research Center for Oncology, Rostov-on-Don, Russian Federation.

SPIN: 5151-9405, AuthorID: 1194338


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



K. V. Kolomiets
National Medical Research Centre for Oncology
Russian Federation

 

Karina V. Kolomiets – resident doctor, National Medical Research Center for Oncology, Rostov-on-Don, Russian Federation.

ORCID: https://orcid.org/0000-0002-3939-8410, SPIN: 4608-6300, AuthorID: 1108400


Competing Interests:

the authors state that there are no conflicts of interest to disclose.



References

1. Rasulov RI, Dvornichenko VV, Muratov AA, Songolov GI, Mozgunov DV. Primary retroperitoneal tumors: past and present (the literature review). Siberian Medical Journal. 2015;7:5–14. (In Russ.). EDN: VZGEUD

2. Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, et al. Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Ann Surg. 2016 May;263(5):1002–1009. https://doi.org/10.1097/SLA.0000000000001447

3. Gamboa AC, Ethun CG, Switchenko JM, Lipscomb J, Poultsides GA, Grignol V, et al. Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan? J Am Coll Surg. 2019 Nov;229(5):449–457. https://doi.org/10.1016/j.jamcollsurg.2019.07.010

4. Tseng WW, Wang SC, Eichler CM, Warren RS, Nakakura EK. Complete and safe resection of challenging retroperitoneal tumors: anticipation of multi-organ and major vascular resection and use of adjunct procedures. World J Surg Oncol. 2011 Nov 4;9:143. https://doi.org/10.1186/1477-7819-9-143

5. Kit OI, Kasatkin VF, Maksimov AYu Moroshan AN. Surgical treatment of non-organ retroperitoneal tumors. Palliative Medicine and Rehabilitation. 2012;1:27–29. (In Russ.). EDN: NJILFO

6. Kaprin AD, Ryabov AB, Khomyakov VM, Cheremisov VV, Khoronenko VE, Chissov VI, et al. Resection of the inferior vena cava in locally advanced non-organ retroperitoneal tumors. Oncology. P. A. Herzen Journal. 2017;6(1):28–38. (In Russ.). https://doi.org/10.17116/onkolog20176128-38, EDN: XXKWYR

7. Stilidi IS, Abgarian MG, Nikulin MP, Kalinin AE. Iliac arteries and aortic repair in patients with retroperitoneal sarcoma. Surgery. Journal named after N. I. Pirogov. 2017;(5):14–22. (In Russ.). https://doi.org/10.17116/hirurgia2017514-22, EDN: WDKRLE

8. Tereshin OS, Zotov SP, Zaikov AA. Surgical excision of retroperitoneal tumors involving great vessels. Oncosurgery. 2013;5(4):8–14. (In Russ.). EDN: RVOIHR

9. Quinones-Baldrich W, Alktaifi A, Eilber F, Eilber F. Inferior vena cava resection and reconstruction for retroperitoneal tumor excision. J Vasc Surg. 2012 May;55(5):1386–1393. https://doi.org/10.1016/j.jvs.2011.11.054

10. Song TK, Harris EJ, Raghavan S, Norton JA. Major blood vessel reconstruction during sarcoma surgery. Arch Surg. 2009 Sep;144(9):817–822. https://doi.org/10.1001/archsurg.2009.149


Supplementary files

Review

For citations:


Kit O.I., Maslov A.A., Kolesnikov E.N., Katelnitskaya O.V., Kozhushko M.A., Snezhko A.V., Katsieva T.B., Myagkov R.E., Sanamyants S.V., Anisimov A.E., Kolomiets K.V. Area of combined surgical interventions, including those with an angiosurgical component, in terms of malignant non-organ retroperitoneal tumors’ treatment. South Russian Journal of Cancer. 2023;4(4):6-12. https://doi.org/10.37748/2686-9039-2023-4-4-1. EDN: APGIHL

Views: 429


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2686-9039 (Online)